• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
QRX
Click for more information
0.00% 2.8¢

QRXPHARMA LTD - Announcements

Currently unlisted. watchlist Created with Sketch. Add to my watchlist

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
QRXTrading HaltPRICE SENSITIVE11/11/09
QRXAppendix 4C - Quarterly Report 30 September 2009PRICE SENSITIVE26/10/09
QRXDeal inked with Patheon for the Manufacture of MoxDou CRPRICE SENSITIVE12/10/09
QRXStrategic Alliance for the Development of Venomics AssetsPRICE SENSITIVE24/09/09
QRXMoxDuoIR Demonstrates Fewer Side Effects than PercocetPRICE SENSITIVE25/08/09
QRXPreliminary Final Report - 30 June 2009PRICE SENSITIVE21/08/09
QRXAppendix 4C - Quarterly Report 30 June 2009PRICE SENSITIVE28/07/09
QRXQRxPharma Initiates Comparative Phase 2 Sudy for MoxDuo IVPRICE SENSITIVE23/07/09
QRXAppendix 4C - Quarterly Report 31 March 2009PRICE SENSITIVE27/04/09
QRXSuccessful Completion of Comparative Study for MoxDuoIRPRICE SENSITIVE20/04/09
QRXHalf Yearly Report and Accounts 31 December 2008PRICE SENSITIVE23/02/09
QRXQRxPharma Initiates Second Comparative Study for MoxDuo IRPRICE SENSITIVE19/02/09
QRXAppendix 4C - Quarterly Report December 2008PRICE SENSITIVE28/01/09
QRXTrading Halt
11/11/09PRICE SENSITIVE
QRXAppendix 4C - Quarterly Report 30 September 2009
26/10/09PRICE SENSITIVE
QRXDeal inked with Patheon for the Manufacture of MoxDou CR
12/10/09PRICE SENSITIVE
QRXStrategic Alliance for the Development of Venomics Assets
24/09/09PRICE SENSITIVE
QRXMoxDuoIR Demonstrates Fewer Side Effects than Percocet
25/08/09PRICE SENSITIVE
QRXPreliminary Final Report - 30 June 2009
21/08/09PRICE SENSITIVE
QRXAppendix 4C - Quarterly Report 30 June 2009
28/07/09PRICE SENSITIVE
QRXQRxPharma Initiates Comparative Phase 2 Sudy for MoxDuo IV
23/07/09PRICE SENSITIVE
QRXAppendix 4C - Quarterly Report 31 March 2009
27/04/09PRICE SENSITIVE
QRXSuccessful Completion of Comparative Study for MoxDuoIR
20/04/09PRICE SENSITIVE
QRXHalf Yearly Report and Accounts 31 December 2008
23/02/09PRICE SENSITIVE
QRXQRxPharma Initiates Second Comparative Study for MoxDuo IR
19/02/09PRICE SENSITIVE
QRXAppendix 4C - Quarterly Report December 2008
28/01/09PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 

Top Stories

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
Sales growth pushes Lovisa's fortunes (and shares) upwards Lovisa Holdings Ltd has seen its shares rise more than 2% following a sales update, and on a good day for the consumer discretionary sector
Scientific conference spotlights PYC's work on blindness disease treatment PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.